Sagimet Biosciences Inc. (SGMT) Live Share Price, Invest From India

Sagimet Biosciences Inc. Stock Performance

as on March 24, 2026 at 6:59 am IST

Day's Low
Day's High
$4.73
Day's Price Range
$4.94
$4.87
2.87%
Downside
1.44%
Upside
52 Week's Low
52 Week's High
$1.73
52-Week Price Range
$11.41
$4.87
64.48%
Downside
134.29%
Upside

Sagimet Biosciences Inc. share price movements today

Previous Close: $4.82
Open: $4.90
Volume: 407.8K
Day's Low - High: $4.73 - $4.94
52 Week Low - High: $1.73 - $11.41

Sagimet Biosciences Inc. Historical Returns

1 Month Return: -8.71 %
3 Month Return: -19.8 %
1 Year Return: + 20.8 %
3 Year Return: 0 %
5 Year Return: 0 %

Sagimet Biosciences Inc. Stock Fundamentals & Key Indicators

Check Sagimet Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$157.1M

EPS (TTM)

-1.7106

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-38.20%

Sagimet Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sagimet Biosciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sagimet Biosciences Inc.	BUY	$157.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	125.13%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.56%	29.67	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	56.01%	17.67	31.41%

Stock Returns calculator for Sagimet Biosciences Inc. Stock including INR - Dollar returns

The Sagimet Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sagimet Biosciences Inc. investment value today

Current value as on today

₹1,31,975

Returns

₹31,975

(+31.97%)

Returns from Sagimet Biosciences Inc. Stock

₹22,055 (+22.06%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Sagimet Biosciences Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Sagimet Biosciences Inc.. Average target price of $25.78

Sagimet Biosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Sagimet Biosciences Inc..

What analysts predicted

81.11%UPSIDE

Target Price

$25.78

Current Price

$4.87

Analyzed by

11 Analysts

Target

$25.78

Sagimet Biosciences Inc. target price $25.78, a slight upside of 81.11% compared to current price of $4.87. According to 11 analysts rating.

Sagimet Biosciences Inc. Stock’s Investor Sentiment and Interest

Search interest for Sagimet Biosciences Inc. Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 22, 2026 to March 24, 2026

Change:-76% versus previous 30 day period

Sagimet Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	2	-	-	-	-	-	-	-	-	-
Gross Profit	2	-	-	-	-	-	-	-	-	-
Operating Income	-7	-9	-8	-10	-16	-18	-19	-11	-14	-10
EBITDA	-7	-6	-8	-10	-16	-16	-19	-11	-12	-12
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-8	-6	-8	-14	-16	-18	-10	-12	-9
Income Tax Expense	-1	-1	-8	-10	-	-	-	-	-	-
Net Income	-6	-8	-6	-8	-14	-16	-18	-10	-12	-9
Net Profit Margin	-317.65%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Sagimet Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	2	-	-
Gross Profit	0	0	0	0	2	-	-
Operating Income	-14	-11	-23	-31	-30	-54	-56
EBITDA	-14	-11	-23	-31	-30	-45	-56
Interest Expense	0	-	-	-	-	-	-
Depreciation	0	-	-	-	-	-	-
Income Before Tax	-14	-11	-24	-30	-27	-45	-51
Income Tax Expense	0	0	-23	-31	-2	-	-
Net Income	-14	-11	-24	-30	-27	-45	-51
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1393.80%	0.00%	0.00%

Sagimet Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-6	-8	-14	-16	-18	-10	-12	-9
Operating Cash Flow	-7	-6	-5	-19	-11	-14	-9	-10	-11
Investing Cash Flow	-19	3	-75	0	9	3	-13	0	14
Financing Cash Flow	3	104	0	-	-	-	0	0	-
Change in Cash	-26	101	-80	-18	-1	-11	-22	-9	2

Sagimet Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-11	-24	-30	-27	-45	-51
Operating Cash Flow	-10	-21	-24	-23	-42	-45
Investing Cash Flow	0	-	-32	12	-61	4
Financing Cash Flow	68	9	0	86	104	0
Change in Cash	58	-11	-56	74	0	-40

Insights on Sagimet Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SGMT has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 7 days, SGMT stock has moved down by -6.2%

About Sagimet Biosciences Inc.

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company developing fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. The Company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction associated steatohepatitis (MASH). Denifanstat has been granted Breakthrough Therapy designation by the FDA for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis. The Company is also exploring the use of its FASN inhibitors, which include denifanstat and its pipeline product candidate, TVB-3567, in acne and in select forms of cancer. Denifanstat is being tested in China by its license partner, Ascletis BioScience Co. Ltd., for moderate to severe acne vulgaris and recurrent glioblastoma multiforme in combination with bevacizumab.

Organisation	Sagimet Biosciences Inc.
Headquarters	155 Bovet Road, San Mateo, CA, United States, 94402
CEO	Mr. David A. Happel
E-voting on shares	Click here to vote

Key Management of Sagimet Biosciences Inc.

Name	Title
Dr. Marie O'Farrell Ph.D.	Chief Scientific Officer
Ms. Elizabeth Rozek Esq., J.D.	Chief Legal & Administrative Officer
Mr. Robert D'Urso	Senior Vice President of New Products
Mr. David A. Happel	CEO, President & Director
Mr. Thierry Chauche	CFO & Principal Accounting Officer
Dr. Eduardo Bruno Martins DPhil, M.D., Ph.D.	Chief Medical Officer
Mr. Urs Greber Ph.D.	Co-Founder
Dr. Lucas Pelkmans Ph.D.	Co-Founder

FAQs

What is Sagimet Biosciences Inc. share price today?

Sagimet Biosciences Inc. share price today is $4.87 as on March 24, 2026 at 1:29 am IST at the close of the market. Sagimet Biosciences Inc. share today touched a day high of $4.94 and a low of $4.73.

What is the 52 week high and 52 week low for Sagimet Biosciences Inc. share?

Sagimet Biosciences Inc. share touched a 52 week high of $11.41 on July 25, 2025 and a 52 week low of $1.73 on April 7, 2025. Sagimet Biosciences Inc. stock price today i.e. March 24, 2026 at 1:29 am IST is closed at $4.87,which is 57.32% down from its 52 week high and 181.50% up from its 52 week low.

What is Sagimet Biosciences Inc.'s market capitalisation today?

Sagimet Biosciences Inc. market capitalisation is $0.00T as on March 24, 2026 at 1:29 am IST.

How to invest in Sagimet Biosciences Inc. Stock (SGMT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sagimet Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sagimet Biosciences Inc. Shares that will get you 0.3080 shares as per Sagimet Biosciences Inc. share price of $4.87 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Sagimet Biosciences Inc. Stock (SGMT) from India?

Indian investors can start investing in Sagimet Biosciences Inc. (SGMT) shares with as little as ₹94.058 or $1 (as of March 24, 2026 at 1:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Sagimet Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on March 24, 2026 at 1:39 am IST). Based on Sagimet Biosciences Inc. share’s latest price of $4.87 as on March 24, 2026 at 1:29 am IST, you will get 2.0534 shares of Sagimet Biosciences Inc.. Learn more about fractional shares .